Home / Health / New Heart Health Guidelines: Earlier Cholesterol Treatment Urged
New Heart Health Guidelines: Earlier Cholesterol Treatment Urged
25 Sep
Summary
- New guidelines emphasize earlier, aggressive cholesterol treatment starting in childhood.
- Advanced tests like ApoB, LpA, and coronary artery calcium are now recommended.
- Personalized risk assessment using calculators guides treatment decisions.
New guidelines released in March 2026 by the American Heart Association and American College of Cardiology advocate for earlier and more aggressive treatment of dyslipidemia. These updated recommendations, last revised in 2018, highlight the strong link between lifelong high cholesterol levels and increased cardiovascular disease risk.
The guidelines introduce new diagnostic tools to personalize patient care. Beyond traditional lipid tests, they now emphasize measuring lipoprotein A (LpA) and apolipoprotein B (ApoB) to better predict risk. Coronary artery calcium (CAC) scoring is also recommended to directly assess plaque buildup in heart arteries.
Clinicians are encouraged to use the PREVENT-ASCVD calculator to determine individual 10-year and 30-year cardiovascular disease risk. This assessment considers factors like BMI, blood pressure, and smoking status, guiding decisions for initiating treatment, including newer medication classes alongside statins, as early as age 30 for high-risk individuals.
These updates promote a shift towards lifelong prevention, with lipid checks recommended for children aged 9-11 and every five years for adults starting at age 19. The guidelines also reinforce lifestyle modifications, including diet, exercise, and weight management, as fundamental to reducing cardiovascular disease risk.
